A major challenge for combating obesity is to identify targetable pathways that can decrease energy intake or increase energy expenditure. One of the most promising biological systems that can be exploited to increase energy expenditure is the thermogenic brown adipose tissue. Unlike white adipose tissue that stores energy in the form of triglycerides, brown adipose tissue oxidize fuels and dissipate energy as heat by uncoupling ATP synthesis from the electron transport chain in a process known as non-shivering thermogenesis. The overall goal of our studies is to understand the molecular mechanisms underlying non-shivering thermogenesis and to exploit these mechanisms to antagonize obesity and associated diseases including Type 2 Diabetes. PGC1?1 is a key transcriptional coactivator that facilitates mitochondrial biogenesis and thermogenesis in brown and adipose tissue. Indeed better understanding novel signal integration points into PGC1?1 are much needed. Identification and characterization of these mechanisms could lead to the discovery of novel ways to boost energy expenditure and antagonize obesity. The objective of this study is to delineate the role protein synthesis plays in regulating PGC1?1 protein expresion in adipose tissue thermogenesis and metabolism. Our preliminary data suggest that insulin strongly induces PGC1?1 protein indepdently of mRNA levels and it is important for adipose tissue thermogenesis. Genetic studies have revealed that insulin signaling is important for brown fat function, but its role in regulating PGC1?1 translation has never been explored. Thus, we hypothesize that a major mode of signal integration into PGC1?1 comes at the level of translation and we aim to decode these mechanisms and biological outcomes in brown adipocytes. We propose the following aims to test this hypothesis: 1.
Aim 1 will define the role of the of the PGC1?1 untranslated region (UTR) in regulating its insulin- dependent translation in primary brown adipose tissue (BAT) cells. The PGC1?1 mRNA transcript has not been fully studied and the function of the UTR is currently unknown. Since we have data strongly suggesting that PGC1?1 is regulated by translation, we are going to test the role of the UTR in this process. 2.
Aim 2 will study the in vivo regulation of PGC1?1 translation by polysome analysis in BAT. The gold standard for measuring translation is the transition of mRNA to translating polyribosomes by the polysome assay. We will delineate the upstream signals that initiate the translation of PGC1?1 in vivo by this assay. 3.
Aim 3 will identify and characterize mRNA binding proteins (RBPs) of PGC1?1 using mRNA capture and mass spectrometry. An open biological question is why are certain mRNAs translated and not others. One hypothesis that we are pursuing is that RBPs allow this specificity by binding certain mRNAs and allowing them to bind the translation complex under preferetial conditions. Here, we are using PGC1?1 as a test case for this and search for novel RBPs.

Public Health Relevance

There are two types of fat in mammals, the ?bad (white) fat? that stores extra calories and the ?good (brown and beige) fat? that expends energy as heat in a process called thermogenesis. The long-term goal of our studies is to find out the molecular differences between the brown/beige fat and the white fat and use these differences to turn ?bad fat? into ?good fat? as a therapeutic strategy to antagonize obesity and associated diseases including diabetes. In this research, we aim to characterize a novel mechanism - translation - by which a master transcriptional coactivator mRNA is turned into function protein, which we believe is essential to for the thermogenic function of brown and beige fat and may be a promising target for the design of anti- obesity drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DK112638-02
Application #
9461953
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Castle, Arthur
Project Start
2017-04-01
Project End
2020-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code